[经验在治疗的眼肌]
N A Ermolenko1, V A Bykova1, O N Krasnorutskaya1
1N.N. Burdenko Voronezh State Medical University, Voronezh, Russia.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
|April 8, 2025
概括
杰本斯综合征是一种罕见的,伴有眼肌,经常面临误诊. 这一案例凸显了超越传统药物的新型治疗方法的必要性,以获得更好的患者结果.
科学领域:
- 神经学 神经学
- 发病学 (Epileptology) 是一个专业的学科.
- 罕见疾病 罕见疾病
背景情况:
- 杰本氏综合征是一种罕见的性疾病,其特征是光敏和眼肌.
- 它是根据国际联盟 (ILAE) 的指导方针进行分类的.
- 由于患病率低,表现复杂,这种疾病往往被低估诊断.
研究的目的:
- 为了强调诊断和治疗Jeavons综合征的挑战.
- 提出一个临床案例,证明标准治疗的局限性.
- 倡导探索的替代治疗策略与眼肌.
主要方法:
- 在PubMed,Embase和Web of Science数据库中进行全面的文献搜索.
- 包括随机对照试验,队列研究,审查和系统审查.
- 分析作者自己与Jeavons综合征相关的临床病例.
主要成果:
- 提出的临床案例表明,目前的治疗方案可能不是普遍有效的.
- 有证据表明,使用非传统疗法有可能改善患者的治疗结果.
- 审查强调了诊断困难和误诊对治疗疗效的影响.
结论:
- 对于Jeavons综合征的创新治疗策略有着迫切的需要.
- 重新考虑治疗方法可以带来更有效的治疗与眼肌.
- 对新型治疗方法的进一步研究是有必要的,以改善受影响个体的生活质量.
相关概念视频
Antiepileptic Drugs: Glutamate Antagonists
258
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
258
Antiepileptic Drugs: Potassium Channel Activators
134
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
134
Arteries of the Lower Limbs
171
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
171
Antiepileptic Drugs: Sodium Channel Blockers
287
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
287
Seizures: Classification
290
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
290
Electroconvulsive Therapy
19
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
19


